The global market for transcatheter treatment devices should grow from $4.0 billion in 2018 to $8.0 billion by 2023 at a compound annual growth rate (CAGR) of 14.8% for the period of 2018-2023.
Report Scope:
Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR, and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic.)
- Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR, and TMVI devices.
- Market characterization, unmet need, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2023.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of transcatheter treatment.
- Profiles of market participants and associations.
Report Includes:
- 28 data tables and 25 additional tables
- An overview of the global market for transcatheter treatment technologies
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Analyses of the market by procedure segments, treatment approaches, and by region
- Detailed market sizing and analyses of the various transcatheter devices and technologies in use or under development
- Description of qualitative and quantitative factors that are driving the global market
- Description of key marketed and pipeline devices and technologies
- Profiles of major companies of the industry including, Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd. and Valcare Inc.
Summary
The global market for transcatheter treatment devices was worth nearly REDACTED in 2017. The market is expected to reach nearly REDACTED in 2018 and approximately REDACTED by 2023, increasing at a compound annual growth rate (CAGR) of REDACTED from 2018 through 2023. This high growth is fueled by increasing acceptance of transcatheter procedures (e.g., TAVR/TAVI and TMVR/TMVI) and increasing diagnosis of heart valve disease (e.g., aortic stenosis, mitral regurgitation, etc.) worldwide.
In 2017, the U.S. accounted for REDACTED of the global market, or REDACTED. The U.S. market should approach nearly REDACTED in 2018 and reach REDACTED by 2023, increasing at a CAGR of REDACTED from 2018 through 2023. Regionally, the U.S. is expected to maintain dominance in the global market of transcatheter treatment devices. Those wishing to invest in the transcatheter treatment devices market ought to strongly consider high-growth areas such as transcatheter aortic valve repair (TAVR), transcatheter mitral valve implantation (TMVI), and transcatheter mitral valve repair (TMVR) devices and technologies. The market is growing primarily due to the growing geriatric population, increasing
prevalence of chronic diseases, continuous technological advancements, increasing adoption of transcatheter techniques, and positive reimbursement and other healthcare reforms.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Structural Heart Valve Disease
Structural Heart Disease
Spectrum of Structural Heart Disease
Valvular Heart Disease
Symptoms and Risk Factors of Structural Heart Disease
Causes of Structural Heart Disease
Rheumatic Fever
Mitral Valve Prolapse
Peripheral Artery Disease
Cardiovascular Disease
Aortic Aneurysm
Obesity
Diagnosis of Structural Heart Disease
Treatment of Structural Heart Disease
Management Through Medication
Surgical Intervention: Heart Valve Repair and Replacement
Tobacco Smoking and Heart Disease
Aging, Gender, and Structural Heart Diseases
Global Demographics
U.S. Demographics
European Demographics
Japanese Demographics
Current Challenges and Future Directions
Chapter 4 Aortic Valve Disease
Disease Overview
Types of Aortic Stenosis
Acquired Aortic Stenosis
Congenital Aortic Stenosis
Mild and Moderate Aortic Stenosis
Severe Aortic Stenosis
Asymptomatic Aortic Stenosis
Symptomatic Aortic Stenosis
Causes, Risk Factors, and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Doppler Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SAVR)
Transcatheter Treatment (TAVR/TAVI)
Aortic Valve Repair Versus Aortic Valve Replacement
Types of Transcatheter Approaches
Open Surgical Repair (SAVR) Versus Transcatheter Treatment (TAVR/TAVI)
TAVR and TAVI Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Self-expandable Versus Balloon-expandable Devices
Unmet Need
Current Challenges and Future Developments
Chapter 5 Mitral Valve Disease
Disease Overview
Types of Mitral Regurgitation
Degenerative Mitral Regurgitation
Functional Mitral Regurgitation
Mild and Moderate Mitral Stenosis
Severe Mitral Stenosis
Asymptomatic Mitral Stenosis
Symptomatic Mitral Stenosis
Causes, Risk Factors, and Symptoms
Causes
Symptoms
Risk Factors
Epidemiology and Economic Burden
Diagnosis
Standard Echocardiography
Multimodality Imaging
Other Techniques
Treatment
Open Surgical Treatment (SMVR)
Transcatheter Treatment (TMVR and TMVI)
Mitral Valve Repair Versus Mitral Valve Replacement
Types of Transcatheter Approaches
Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
TMVR Complications
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Other Less Invasive (MIS) Mitral Valve Technologies
Unmet Need
Current Challenges and Future Developments
Chapter 6 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Segment
Market Size and Growth Analysis, by Procedure Approach
Market Size and Growth Analysis, by Procedure (TAVR/TAVI and TMVR)
Heart Valve Market: Traditional Heart Valves (Tissue Heart Valves and Mechanical Heart Valves) Versus Transcatheter Heart Valves
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Chapter 7 Competitive Landscape in Transcatheter Treatment Devices Market
Competitive Landscape in Transcatheter Treatment Devices Market
Chapter 8 Market Strategies in the Transcatheter Treatment Devices Market
Market Consolidation in Cardiovascular Devices Market
Mergers and Acquisitions in Transcatheter Treatment Devices Market
Recent Mergers and Acquisitions
Venus Medtech Acquired Intervalve Inc.
LivaNova PLC Acquired Caisson Interventional LLC
Boston Scientific Acquired Symetis SA
Boston Scientific Acquired Neovasc’s Advanced Biological Tissue Manufacturing Assets along with 15% Stake in Neovasc Inc.
Edwards Lifesciences Acquired Valtech Cardio Ltd.
Venus Medtech Inc. Acquired Transcatheter Technologies’ Technology Portfolio
Medtronic Acquired Twelve Inc.
Abbott Acquired Tendyne Holdings
Edwards Lifesciences Acquired CardiAQ Valve Technologies Inc.
Micro Interventional Devices Acquired Endovalve Inc.
Boston Scientific Acquired Sadra Medical Inc.
LoneStar Heart Acquired Cardiopolymers Inc.
Abbott Laboratories Acquired Evalve Inc.
Medtronic Acquired Ventor Technologies Ltd.
The Bracco Group acquired Heart Leaflet Technologies Inc. (HLT)
Minority Stakes and Future Options to Acquire
Abbott Laboratories Secures an Option to Buy Cephea Valve Technologies Inc.
Sorin Acquired Minority Stake in HighLife SAS
Boston Scientific Secures an Option to Buy MValve Technologies Ltd.
Sorin Group Acquired Minority Stake in Cardiosolutions Inc.
Future Strategic Landscape
Chapter 9 Regulatory Structure: Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union (EU)
Japan
Chapter 10 Pricing and Reimbursement: Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Chapter 11 Conclusions—Outlook for Transcatheter Treatment Devices
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Long-term Outlook for Transcatheter Treatments
Chapter 12 Company Profiles
ABBOTT LABORATORIES
BIOTRONIK
BOSTON SCIENTIFIC CORP.
BRACCO SPA
BRAILE BIOMÉDICA
CARDIAC DIMENSIONS INC.
CEPHEA VALVE TECHNOLOGIES INC.
COLIBRI HEART VALVE LLC
DIRECT FLOW MEDICAL INC.
EDWARDS LIFESCIENCES CORP.
GORMAN CARDIOVASCULAR RESEARCH GROUP
HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
HIGHLIFE SAS
JENAVALVE TECHNOLOGY INC.
LABORATORIES INVALV
LIVANOVA PLC
LONESTAR HEART INC.
MEDTRONIC INC.
MICRO INTERVENTIONAL DEVICES INC.
MICROPORT SCIENTIFIC
MITRAGEN INC.
MITRALIX LTD.
MITRALTECH LTD.
MITRASSIST LTD.
MITRICARES SAS
MITRAL HEAL LTD.
MITRALIGN INC.
MVRX INC.
NAKOSTECH SARL
NAVIGATE CARDIAC STRUCTURES INC.
NEOVASC INC.
NEW VALVE TECHNOLOGY (NVT) AG
SINO MEDICAL SCIENCE TECHNOLOGY INC.
ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
TAU-PNU MEDICAL CO. LTD.
THUBRIKAR AORTIC VALVE INC.
TRANSCATHETER TECHNOLOGIES GMBH
TRANSMURAL SYSTEMS
VASCULAR INNOVATIONS CO. LTD.
VALCARE INC.
VALVEXCHANGE INC.
VENUS MEDTECH INC.
Chapter 13 Appendix A: List of Acronyms
Chapter 14 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)
Trends Market Research © Copyright 2020. All Rights Reserved.